Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.6.6 was added, replacing the previous v3.6.5 to reflect a newer version of the study record metadata.SummaryDifference0.0%

- Check11 days agoChange DetectedA funding reference line '2015 ( U.S. NIH Grant/Contract )' was added to the study record, indicating NIH support for the trial.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision tag v3.6.5 has been added, replacing the previous v3.6.4 to indicate the latest software release for the page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3, indicating a new build. This is a maintenance/version update and does not reflect changes to the study content or its presentation.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, indicating a version update to the page or its underlying template. It does not appear to modify core study content or participant information.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardized the Intervention/Treatment label, replacing the previous Intervention / Treatment. The page now also shows the recruitment status as 'No longer looking for participants', indicating that enrollment has ended.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.